Glecaprevir-pibrentasvir to treat chronic hepatitis C virus infection in Asia: two multicentre, phase 3 studies-a randomised, double-blind study (VOYAGE-1) and an open-label, single-arm study (VOYAGE-2)
김윤준, Burroughs, M, Asatryan, A, Jia, JD, Hou, JL, Heo, J, Xie, Q, Zhang, MX, Lim, SG, Fredrick, LM, Lu, WJ, Liu, W, Kalluri, HV, Krishnan, P, Tripathi, R, Wei, L, Wang, GQ, Alami, NN, Xie, W, Mobashery, N
LANCET GASTROENTEROLOGY & HEPATOLOGY, 202009